CLX CLOROX CO /DE/ Insider Trading

Director Breber buys 5,000 CLX shares at open market; stock trading well below 52-week highs amid recent weakness.

Director Pierre R Breber purchased over 5,000 shares of Clorox at the open market, representing a meaningful addition to his position. The timing is notable: the stock has pulled back significantly from its highs and is currently near the lower bound of its recent range, suggesting Breber is buying into weakness rather than chasing momentum. Clorox remains a profitable company with solid fundamentals and a reasonable valuation multiple, making this the type of backdrop where insider buying can signal genuine conviction. As a director with board-level insight into the company's strategy and operations, Breber's willingness to deploy capital here—particularly after a sharp recent decline—indicates he may view the current price as attractive relative to long-term value. This type of buying by a company insider during a pullback merits monitoring as a potential contrarian signal.

Director Pierre Breber buys 4,000 CLX shares at $104.13, increasing holdings by 44.4% to 13,000 shares

Director Pierre Breber purchased 4,000 shares of Clorox at $104.13 on 2025-11-21, representing a substantial 44.4% increase in his holdings. The transaction occurred when the stock was trading 37.8% below its 52-week high and down 8.8% over the prior 30 days. However, his prior buy at this ticker on 2025-05-07 did not result in a well-timed entry, with negative 90-day and 30-day returns, indicating that timing accuracy at Clorox specifically has not been reliable despite his strong 95.00% 90-day win rate across his broader cross-ticker trading activity. The company's fundamentals show modest revenue of $1.4B with net income of $80.0M and annual revenue growth of only +0.2%, reflecting a mature business with limited organic growth momentum.

CLX EVP Reynolds sold 15,041 shares at $123.78; holds 54,221 post-transaction. Stock -25.8% from 52-week high.

Reynolds Eric H (EVP – Chief Operating Officer) sold 15,041 shares at $123.78, reducing his stake by -21.7% to 54,221 shares held post-transaction. Clorox trades at $125.87 today, down 25.8% from its 52-week high of $169.74, placing the transaction near recent price recovery following the 90-day decline of -0.8%. The company's fundamentals remain stable with $1.7B quarterly revenue and a P/E of 12.57, though annual revenue growth of +0.2% indicates minimal expansion. As a material holder, Reynolds' divestiture of this magnitude merits disclosure attention; the sale's timing relative to current valuations and the officer's remaining substantial holdings (54.2K shares) should be tracked against broader insider activity and company guidance.

Director Breber Pierre R buys 4,000 CLX shares at $136.57; first position (0→4.0K shares); stock at -20.6% from 52-week high.

Breber's purchase of 4,000 shares at $136.57 on 2025-05-07 establishes an initial position in Clorox after no prior holdings, representing a new director-level commitment to the company. The transaction occurs while CLX trades -20.6% from its 52-week high of $169.74 and -9.2% over 90 days, placing the purchase in a period of relative weakness. His cross-ticker track record shows 20 prior buys across his open-market history, indicating a pattern of accumulating positions rather than net selling activity. However, the stock's fundamentals show annual revenue declining 4.0% and a P/E of 23.94, with the company generating $186.0M net income on $1.7B quarterly revenue, warranting close attention to execution and near-term guidance.

Marriner Kirsten sells 8,227 shares for $1,246,201.06; holds 26,305 shares post-transaction (-23.8%)

Marriner Kirsten, EVP – Chief People Officer at Clorox, executed 5 separate sales on March 10-11, 2025, totaling 8,227 shares for $1,246,201.06 at a blended average price of $151.48 per share. The transaction reduced her holding from 34,532 shares to 26,305 shares. At the current price of $147.50, the stock is trading -13.1% below its 52-week high of $169.74, yet Clorox's fundamentals show net income of $193,000,000.00 on quarterly revenue of $1,686,000,000.00, with an elevated P/E of 39.76. The annual revenue growth rate is -4.0%, reflecting headwinds in the consumer staples sector. Kirsten's retention of 26.3K shares demonstrates continued material ownership alignment, even as the company faces revenue contraction.